Markers of abuse liability of short- vs long-acting opioids in chronic pain patients: A randomized cross-over trial

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 1, 2009, Pages 98-107

  Wilsey, Barth L ^a,b   Fishman, Scott ^b   Li, Chin Shang ^b,c   Storment, Jeanna ^b   Albanese, Anthony ^a  

^a VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Davis Clinic PC   (United States)

Author keywords

Abuse liability; Cue reactivity; Long acting opioids; Prescription drug abuse; Short acting opioids

Indexed keywords

HYDROCODONE BITARTRATE PLUS PARACETAMOL; MORPHINE; PLACEBO;

ADULT; AGITATION; ARTICLE; ASSOCIATION; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DYSPHORIA; EUPHORIA; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; VISUAL ANALOG SCALE; WITHDRAWAL SYNDROME;

ADULT; ANALGESICS, OPIOID; BEHAVIOR, ADDICTIVE; CHRONIC DISEASE; CONSCIOUS SEDATION; CROSS-OVER STUDIES; CUES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCODONE; MALE; MIDDLE AGED; MORPHINE; OPIOID-RELATED DISORDERS; PAIN; QUESTIONNAIRES; SELF ADMINISTRATION; STRESS, PHYSIOLOGICAL; SUBSTANCE ABUSE DETECTION; TIME FACTORS;

EID: 70349194368     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.07.014     Document Type: Article

References (59)

1. Agarwal S., Polydefkis M., Block B., Haythornthwaite J., and Raja S.N. Transdermal fentanyl reduces pain and improves functional activity in neuropathic pain states. Pain Med 8 (2007) 554-562
2. Akbik H., Butler S.F., Budman S.H., Fernandez K., Katz N.P., and Jamison R.N. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage 32 (2006) 287-293
3. Becker W.C., Sullivan L.E., Tetrault J.M., Desai R.A., and Fiellin D.A. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend 94 (2008) 38-47
4. Beglinger L.J., Gaydos B., Tangphao-Daniels O., Duff K., Kareken D.A., Crawford J., Fastenau P.S., and Siemers E.R. Practice effects and the use of alternate forms in serial neuropsychological testing. Arch Clin Neuropsychol 20 (2005) 517-529
5. Benedict R.H., and Zgaljardic D.J. Practice effects during repeated administrations of memory tests with and without alternate forms. J Clin Exp Neuropsychol 20 (1998) 339-352
6. Benedict R., Schretlen D., Groninger L., and Brandt J. Verbal learning test-revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol (Neuropsychol Dev Cogn) 12 (1998) 43-55
7. Bigelow G.E. Human drug abuse liability assessment: opioids and analgesics. Br J Addict 86 (1991) 1615-1623
8. Black M.L., Hill J.L., and Zacny J.P. Behavioral and physiological effects of remifentanil and alfentanil in healthy volunteers. Anesthesiology 90 (1999) 718-726
9. Brown R.T., Zuelsdorff M., and Fleming M. Adverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant pain. J Opioid Manag 2 (2006) 137-146
10. Busto U.E., Zawertailo L.A., Kaplan H.L., and Sellers E.M. Identifying appropriate subjects for abuse liability studies using prestudy pharmacological testing. Can J Clin Pharmacol 6 (1999) 103-110
11. Butler S.F., Budman S.H., Fernandez K., and Jamison R.N. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 112 (2004) 65-75
12. Butler S.F., Fernandez K., Benoit C., Budman S.H., and Jamison R.N. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain 9 (2008) 360-372
13. Carter B.L., and Tiffany S.T. Meta-analysis of cue-reactivity in addiction research. Addiction 94 (1999) 327-340
14. Carter B.L., and Tiffany S.T. The cue-availability paradigm: the effects of cigarette availability on cue reactivity in smokers. Exp Clin Psychopharmacol 9 (2001) 183-190
15. Chapman S.L., Byas-Smith M.G., and Reed B.A. Effects of intermediate- and long-term use of opioids on cognition in patients with chronic pain. Clin J Pain 18 (2002) S83-S90
16. Chou R., Clark E., and Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symptom Manag 26 (2003) 1026-1048
17. Collie A., Maruff P., Darby D.G., and McStephen M. The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. J Int Neuropsychol Soc 9 (2003) 419-428
18. Comer S.D., Ashworth J.B., Foltin R.W., Johanson C.E., Zacny J.P., and Walsh S.L. The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend 96 (2008) 1-15
19. Cooney N.L., Litt M.D., Morse P.A., Bauer L.O., and Gaupp L. Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. J Abnorm Psychology 106 (1997) 243-250
20. Drummond D.C. What does cue-reactivity have to offer clinical research?. Addiction 95 Suppl 2 (2000) S129-S144
21. Drummond D.C., Litten R.Z., Lowman C., and Hunt W.A. Craving research: future directions. Addiction 95 Suppl 2 (2000) S247-S255
22. Field M., and Duka T. Cue reactivity in smokers: the effects of perceived cigarette availability and gender. Pharmacol Biochem Behav 78 (2004) 647-652
23. Gaertner J., Radbruch L., Giesecke T., Gerbershagen H., Petzke F., Ostgathe C., Elsner F., and Sabatowski R. Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients. Acta Anaesthesiol Scand 50 (2006) 664-672
24. Haertzen C., and Hickey J. Addiction Research Center Inventory (ARCI): measurement of euphoria and other drug effects. In: Bozarth M. (Ed). Methods of assessing the reinforcing properties of abused drugs (1987), Springer-Verlag, New York 489-524
25. Heaton R., and Marcotte T. Clinical neuropsychological tests and assessment techniques. In: Boller F., Grafman J., and Rizzolatti G.E. (Eds). Handbook of neuropsychology (2000), Elsevier Science BV, Amsterdam
26. Heit H.A. The truth about pain management: the difference between a pain patient and an addicted patient. Eur J Pain 5 Suppl A (2001) 27-29
27. Juliano L.M., and Brandon T.H. Reactivity to instructed smoking availability and environmental cues: evidence with urge and reaction time. Exp Clin Psychopharmacol 6 (1998) 45-53
28. Kamboj S.K., Tookman A., Jones L., and Curran H.V. The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain 117 (2005) 388-395
29. Katz N., Fernandez K., Chang A., Benoit C., and Butler S.F. Internet-based survey of nonmedical prescription opioid use in the United States. Clin J Pain 24 (2008) 528-535
30. Klove H. Clinical neuropsychology. In: Forster F. (Ed). The medical clinics of North America (1963), Saunders, New York, NY
31. Kozlowski L.T., and Wilkinson D.A. Use and misuse of the concept of craving by alcohol, tobacco, and drug researchers. Br J Addict 82 (1987) 31-45
32. Lorenz J., Beck H., and Bromm B. Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain 73 (1997) 369-375
33. Marin R., Cyhan T., and Miklos W. Sleep disturbance in patients with chronic low back pain. Am J Phys Med Rehabil 85 (2006) 430-435
34. Martin W.R., Sloan J.W., Sapira J.D., and Jasinski D.R. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12 (1971) 245-258
35. Max M., Payne R., Edwards W., and Sunshine A. Principles of analgesic use in the treatment of acute pain and cancer pain. 4th Ed (1999), American Pain Society, Chicago
36. McCarberg B.H., and Barkin R.L. Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Ther 8 (2001) 181-186
37. Moldofsky H. The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes. Jt Bone Spine 75 (2008) 397-402
38. NIDA. Central nervous system intersections of drug addiction, chronic pain and analgesia (2008). http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-017.html http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-017.html. Accessed on 12/2/2008
39. Ooteman W., Koeter M.W., Vserheul R., Schippers G.M., and van den Brink W. Measuring craving: an attempt to connect subjective craving with cue reactivity. Alcohol Clin Exp Res 30 (2006) 57-69
40. Panjabi SS, Panjabi RS, Shepherd MD, Lawson KA, Johnsrud M, Barner J. Extended-release, once-daily morphine (Avinza) for the treatment of chronic nonmalignant pain: effect on pain, depressive symptoms, and cognition. Pain Med 2008;9(8):985-93.
41. Passik S.D., and Kirsh K.L. The interface between pain and drug abuse and the evolution of strategies to optimize pain management while minimizing drug abuse. Exp Clin Psychopharmacol 16 (2008) 400-404
42. Roehrs T., and Roth T. Sleep and pain: interaction of two vital functions. Semin Neurol 25 (2005) 106-116
43. SAMHSA. Nonmedical use of prescription pain relievers (2004). http://oas.samhsa.gov/2k4/pain/pain.htm May 21, http://oas.samhsa.gov/2k4/pain/pain.htm. Accessed on 11/20/2008
44. Streeter C.C., Gulliver S.B., Baker E., Blank S.R., Meyer A.A., Ciraulo D.A., and Renshaw P.F. Videotaped cue for urge to drink alcohol. Alcohol Clin Exp Res 26 (2002) 627-634
45. Taylor R.C., Harris N.A., Singleton E.G., Moolchan E.T., and Heishman S.J. Tobacco craving: intensity-related effects of imagery scripts in drug abusers. Exp Clin Psychopharmacol 8 (2000) 75-87
46. Tiffany S.T., and Drobes D.J. Imagery and smoking urges: the manipulation of affective content. Addict Behav 15 (1990) 531-539
47. Turk D.C., Swanson K.S., and Gatchel R.J. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain 24 (2008) 497-508
48. Walker D.J., Zacny J.P., Galva K.E., and Lichtor J.L. Subjective, psychomotor, and physiological effects of cumulative doses of mixed-action opioids in healthy volunteers. Psychopharmacology (Berl) 155 (2001) 362-371
49. Walsh S.L., Nuzzo P.A., Lofwall M.R., and Holtman Jr. J.R. The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers. Drug Alcohol Depend 98 (2008) 191-202
50. Wasan A.D., Butler S.F., Budman S.H., Benoit C., Fernandez K., and Jamison R.N. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain 23 (2007) 307-315
51. Wechsler D. Wechsler adult intelligence scale administration and scoring manual (1997), Harcourt Brace & Co, San Antonio, TX
52. Wilsey BL, Fishman SM, Tsodikov A, Ogden C, Symreng I, Ernst A. Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department. Pain Med 2008;9(8):1107-17.
53. Wilson S.J., Sayette M.A., and Fiez J.A. Prefrontal responses to drug cues: a neurocognitive analysis. Nat Neurosci 7 (2004) 211-214
54. Zacny J.P. Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers. Psychopharmacology (Berl) 165 (2003) 146-156
55. Zacny J.P., Conley K., and Marks S. Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers. J Pharmacol Exp Ther 280 (1997) 1159-1169
56. Zacny J.P., Hill J.L., Black M.L., and Sadeghi P. Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers. J Pharmacol Exp Ther 286 (1998) 1197-1207
57. Zacny J., Bigelow G., Compton P., Foley K., Iguchi M., and Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend 69 (2003) 215-232
58. Zacny J.P., Gutierrez S., and Bolbolan S.A. Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users. Drug Alcohol Depend 78 (2005) 243-252
59. Zelman D.C., Brandenburg N.A., and Gore M. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain 22 (2006) 681-685